PAMS
VRDN icon

Pictet Asset Management (Switzerland)’s Viridian Therapeutics VRDN Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		$25.3M Buy
1,061,517
+18,552
+2% +$441K 0.03% 413
2023
Q1 		$26.5M Buy
+1,042,965
New +$26.5M 0.03% 392